The use of anti-inflammatory drug, PTX, inhibited hippocampal TNF-α and modulated hippocampal apoptosis, amyloid plaque deposition, Tau aggregation, and cortical cholinergic activity and therefore resulted in improved cognition in the CuSO4-induced AD rat model. The gene discussed is MAPT; the disease is Alzheimer disease.